Atherosclerotic Disease
Advertisement
Researchers have developed a polygenic risk score to analyze the link between dysfunctional endothelial and CAD.
This structural discovery is a step toward the development of next-generation therapies to modulate LDL.
The FDA recently announced a first time proposed rule which would require the tobacco industry to lower nicotine levels.
Researchers explored how immune checkpoint inhibitors interact with immune cells in arterial plaques.
A study found a comparable reduction in LDL-C with statins and bempedoic acid in patients with and without ASCVD.
Higher lipoprotein(a) levels are associated with an increased progression of coronary plaque burden.
Researchers developed an at-home questionnaire test that quickly identifies people at high risk of heart attack.
People with heart disease could benefit from a low-sodium diet but, on average, consume twice the recommended amount of salt.
US veterans have a disproportionately high risk of atherosclerotic cardiovascular disease and a low adherence to LLT.
Older firefighters may have more thrombotic risk factors that contribute to a higher risk of coronary heart disease.
Distinct variations of coronary artery calcium-derived coronary artery heart disease exist among retired NFL players.
A remote, algorithm-based program is effective at helping patients achieve optimal LDL-C levels for at least 12 months.
More than half of adults in the United States don't know that heart disease is the leading cause of death nationwide.
Dr. Marc Bonaca discusses the VOYAGER PAD study, which showed the efficacy of rivaroxaban in lower extremity PAD.
Dr. Eugenia Alleva discusses a study that found women with dysmenorrhea have increased cardiovascular risk.
Dr. Ijeoma Eleazu talks about the harmful impact of cumulative stress on cardiovascular health.
James K. Min, MD, founder and CEO of Cleerly, talks about improved screening for heart disease using a digital care platform.
Elevated lipoprotein(a) increases the risk of major adverse cardiovascular events independent of ASCVD risk scores.
Researchers analyzed the long-term impact of TAVR on coronary arteries and cardiac hemodynamics.
A cardio-oncology rehabilitation program can benefit cancer survivors at high risk of cardiovascular disease.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.